Croient Pharma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Croient Pharma Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $263.0K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Croient Pharma Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $263.0K Trade | TransData Nexus

Croient Pharma Private Limited

Indian Pharmaceutical Exporter · Advanced Oncology Specialist · $263.0K Total Trade · DGFT Verified

Croient Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $263.0K across 2 products in 2 therapeutic categories. Based on 14 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Tofacitinib ($150.0K), Terbutaline ($113.0K), .

Croient Pharma Private Limited — Export Portfolio & Destination Treemap

Croient Pharma Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Croient Pharma Private Limited? — Company Overview & Market Position

Croient Pharma Private Limited is an Indian pharmaceutical company established on February 14, 2012, in Thane, Maharashtra. The company is registered under the Corporate Identification Number (CIN) U24233MH2012PTC226900 and is classified as a private, non-government company. Its authorized share capital is ₹4,500,000, with a paid-up capital of ₹4,050,000. The registered office is located at Shop No. 2, Srushti Society, Kolbad Road, Thane (West), Maharashtra 400601, India. The company's primary business activity is the manufacture of pharmaceuticals, medicinal chemicals, and botanical products.

What Does Croient Pharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Tofacitinib$150.0K 2Terbutaline$113.0K

Croient Pharma Private Limited Therapeutic Categories — 2 Specializations

Product Portfolio — Top 2 by Export Value

Croient Pharma Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Tofacitinib	Advanced Oncology	$150.0K	3	3.8%	4
2	Terbutaline	Respiratory & OTC	$113.0K	11	3.2%	3

Croient Pharma Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $263.0K. The top category is Advanced Oncology (57.0% of portfolio), followed by Respiratory & OTC (43.0%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Croient Pharma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Croient Pharma Private Limited operates manufacturing facilities in Thane, Maharashtra. Specific details regarding plant capacities and specializations are not publicly disclosed. The company's focus is on the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Given the absence of publicly available information on manufacturing capacities and specializations, a detailed assessment cannot be provided.

3Key Leadership

The key executives of Croient Pharma Private Limited include:

Shrikant Hambirrao Rane
Pawankumar Babasaheb Ankalkope
Dinesh Balkrishna Sawant

All three directors have been associated with the company since its inception on February 14, 2012. Specific roles and responsibilities of each director are not publicly detailed.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Croient Pharma Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Croient Pharma Private Limited's export activities, as per TransData Nexus proprietary trade data, include shipments totaling $263,000 across 14 transactions, with products spanning two therapeutic categories. The top two exported products are Tofacitinib and Terbutaline, accounting for 57% and 43% of the export value, respectively. However, specific details regarding regulatory filings, approvals, and market access status in the US, EU, UK, Australia, and Japan are not publicly available. The company's export portfolio is concentrated, with the top two products comprising 100% of the export value, indicating a lack of diversification in its international market presence.

2Emerging Markets

Croient Pharma Private Limited's export data indicates a focus on advanced oncology and respiratory & OTC therapeutic categories. While the company has engaged in exports, specific information regarding its penetration into African, Latin American, and Southeast Asian markets, as well as WHO prequalification status, is not publicly available. The lack of diversification in its export portfolio suggests limited engagement in emerging markets.

3Geographic Strategy

Croient Pharma Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Croient Pharma Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not publicly available. The company's export data does not provide insights into its regulatory standing with the FDA. Without access to detailed regulatory filings and inspection records, a comprehensive assessment of the company's FDA status cannot be conducted.

2WHO & EU GMP

There is no publicly available information regarding Croient Pharma Private Limited's WHO prequalification status or EU Good Manufacturing Practice (GMP) certifications. The company's export data does not indicate compliance with these international standards. Without access to certification records, it is challenging to assess the company's adherence to WHO and EU GMP requirements.

3CDSCO & Indian Regulatory

Croient Pharma Private Limited is registered with the Ministry of Corporate Affairs under CIN U24233MH2012PTC226900. Specific details regarding its manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), approvals from state drug controllers, and export No Objection Certificates (NOCs) are not publicly available. The company's export data does not provide insights into its compliance with Indian regulatory requirements.

Croient Pharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Croient Pharma Private Limited operates in the pharmaceutical industry, focusing on finished pharmaceutical formulations. The company's export data indicates a concentration in advanced oncology and respiratory & OTC therapeutic categories. While specific competitors in these categories are not identified, the lack of diversification in Croient Pharma's export portfolio suggests potential challenges in competing with companies offering a broader range of products and therapeutic areas. A more diversified product portfolio could enhance the company's competitiveness in the global market.

2Key Differentiators

Croient Pharma Private Limited's export portfolio is concentrated on two products—Tofacitinib and Terbutaline—across two therapeutic categories. This focus may allow the company to develop specialized expertise in these areas. However, the lack of product diversification could limit the company's ability to meet a broader range of market demands and adapt to changing market conditions.

3Strategic Position

Croient Pharma Private Limited's current strategic direction appears to be focused on the export of finished pharmaceutical formulations in specific therapeutic categories. The company's limited product and market diversification may expose it to risks associated with market fluctuations and regulatory changes. Future strategic initiatives could include expanding the product portfolio, entering new therapeutic areas, and diversifying into emerging markets to enhance growth prospects and mitigate risks.

Buyer Due Diligence Brief — Evaluating Croient Pharma Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Croient Pharma Private Limited's export data indicates a focus on two products across two therapeutic categories, with a total export value of $263,000 across 14 shipments. The concentration of exports suggests a reliance on a limited number of products and markets. Without information on the company's supply chain practices, manufacturing capabilities, and quality control measures, it is challenging to assess its overall track record, export volume consistency, and reliability.

2Certifications to Verify

Importers considering Croient Pharma Private Limited should verify the following certifications:

FDA Facility Registration: Confirm the company's registration status with the U.S. Food and Drug Administration.
WHO-GMP Certification: Verify compliance with World Health Organization Good Manufacturing Practices.
EU GMP Certification: Ensure adherence to European Union Good Manufacturing Practices.

Frequently Asked Questions — Croient Pharma Private Limited

How many pharmaceutical products does Croient Pharma Private Limited export from India?

Croient Pharma Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Tofacitinib ($150.0K), Terbutaline ($113.0K). Total export value is $263.0K.

What is Croient Pharma Private Limited's total pharmaceutical export value?

Croient Pharma Private Limited's total pharmaceutical export value is $263.0K, based on 14 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Croient Pharma Private Limited cover?

Croient Pharma Private Limited exports across 2 therapeutic categories. The largest are Advanced Oncology (57.0%, 1 products), Respiratory & OTC (43.0%, 1 products).

Get Full Croient Pharma Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.